Pictet Asset Management (UK)’s Aerie Pharmaceuticals AERI Stock Holding History

Pictet Asset Management (UK)’s Portfolio AERI Stock Details AERI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-930,723	Closed	-$27.5M	–	1050
2019 Q2	$27.5M	Buy	930,723 +120,313	+15%	+$4.64M	0.06%	329
2019 Q1	$38.5M	Buy	810,410 +240,322	+42%	+$10.6M	0.08%	278
2018 Q4	$20.6K	Buy	570,088 +233,809	+70%	+$11M	0.05%	366
2018 Q3	$20.7M	Sell	336,279 -76,391	-19%	-$4.91M	0.04%	409
2018 Q2	$27.9M	Sell	412,670 -109,322	-21%	-$6.12M	0.07%	327
2018 Q1	$28.3M	Buy	521,992 +203,828	+64%	+$11.4M	0.07%	326
2017 Q4	$19M	Buy	+318,164	New	+$19.3M	0.05%	388
2015 Q2	–	Sell	-12,200	Closed	-$118K	–	897
2015 Q1	$118K	Buy	+12,200	New	+$354K	﹤0.01%	838

Other funds holding AERI

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

FCMI

Foresite Capital Management III Larkspur, California $37.9M AUM 6.87% 1-Year Est. Return

WRF

Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return

PHS

PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return

FCMI

Foresite Capital Management II Larkspur, California $29.2M AUM 44.84% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

FCMI

Foresite Capital Management IV Larkspur, California $237M AUM 107.53% 1-Year Est. Return

Pictet Asset Management (UK)'s AERI Position: Q3 2019 in Review

Pictet Asset Management (UK) sold out of Aerie Pharmaceuticals (AERI) in Q3 2019, closing a stake of 930,723 shares — an estimated $27.5M sold.

Pictet Asset Management (UK) first reported a position in AERI in Q1 2015 and held it in 8 quarters. The position peaked at $38.5M in Q1 2019. 167 funds tracked by Wall St. Rank hold AERI as of Q3 2019.

Pictet Asset Management (UK) reported no remaining Aerie Pharmaceuticals position as of Q3 2019 after selling out during the quarter.
Pictet Asset Management (UK) sold 930,723 Aerie Pharmaceuticals shares in Q3 2019, an estimated $27.5M.
Pictet Asset Management (UK) first reported a position in Aerie Pharmaceuticals in Q1 2015 and held it in 8 quarters.
Pictet Asset Management (UK)'s Aerie Pharmaceuticals position peaked at $38.5M in Q1 2019.
167 funds tracked by Wall St. Rank held Aerie Pharmaceuticals as of Q3 2019.

Based on Pictet Asset Management (UK)'s 13F filing for Q3 2019, filed 14 Nov 2019.